Octopus Biosafety: Approval of the recovery plan by the Lorient Court

On July 23, 2025, Octopus Biosafety announced the adoption of its recovery plan by the Lorient Commercial Court, following a judgment rendered on July 4. After an observation period that began in May 2024 and a merger with TAW, the company is now accessing high value-added markets.

The plan, validated by the court, ensures the continuation of operations and the settlement of liabilities. It provides, in particular, for the settlement of super-privileged debts over six months and the settlement of other debts over six years. SELARL THEVENOT PARTNERS has been appointed to oversee the execution of the plan. The latter aims to guarantee the sustainable development of the company listed on Euronext Access Paris.